Related references
Note: Only part of the references are listed.Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis
Tadashi Nakamura
Modern Rheumatology (2014)
A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Esophageal, Gastroesophageal Junction, and Gastric Carcinoma
Rachel Raab et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2010)
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
C. Frank Bennett et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Development of Apolipoprotein B Antisense Molecules as a Therapy for Hyperlipidemia
Tiffany Thomas et al.
CURRENT ATHEROSCLEROSIS REPORTS (2010)
Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy
Fatima Akdim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Karl Bodin et al.
NATURE (2010)
Susceptibility to AA Amyloidosis in Rheumatic Diseases: A Critical Overview
Laura Obici et al.
ARTHRITIS CARE & RESEARCH (2009)
Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes
Changjie Song et al.
ATHEROSCLEROSIS (2009)
Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100
Rosie Z. Yu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Phase II Trial of OGX-011 in Combination with Docetaxel in Metastatic Breast Cancer
Stephen Chia et al.
CLINICAL CANCER RESEARCH (2009)
Antisense oligonucleotide pharmacokinetics and metabolism
Richard S. Geary
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia
Aaron D. Schimmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Reflections on amyloidosis in Papua New Guinea
Per Westermark et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2008)
Clinical and histological characteristics of renal AA amyloidosis:: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response
Jerome Verine et al.
HUMAN PATHOLOGY (2007)
Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis
C. P. J. Maury et al.
JOURNAL OF INTERNAL MEDICINE (2007)
Eprodisate for the treatment of renal disease in AA amyloidosis
Laura M. Dember et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Natural history and outcome in systemic AA amyloidosis
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever
Isabelle Touitou et al.
ARTHRITIS AND RHEUMATISM (2007)
Interaction between serum amyloid A and leukocytes - A possible role in the progression of vascular complications in diabetes
Elaine Hatanaka et al.
IMMUNOLOGY LETTERS (2007)
Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis
T Nakamura et al.
RHEUMATOLOGY (2006)
Hereditary periodic fever and reactive amyloidosis
JCH van der Hilst et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2005)
Tumor necrosis factor alpha, its soluble receptor I, and-308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis - Implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis
CPJ Maury et al.
ARTHRITIS AND RHEUMATISM (2003)
Phase I trial of ISIS 104838, a 2′-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-α
KL Sewell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Pathology, diagnosis and pathogenesis of AA amyloidosis
C Röcken et al.
VIRCHOWS ARCHIV (2002)
Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein
JD Gillmore et al.
LANCET (2001)
Share Paper
